Cargando…

Enhanceosome transcription factors preferentially dimerize with high mobility group proteins

BACKGROUND: The enhanceosome is an enhancer located upstream of the human interferon β gene, bound by transcription factor (TF) complex of extremely rigid structure. Within these rigid constraints, even a slight change of distances between transcription factor binding sites (TFBS) results in loss of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jankowski, Aleksander, Obara, Paulina, Mathur, Utsav, Tiuryn, Jerzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743414/
https://www.ncbi.nlm.nih.gov/pubmed/26847699
http://dx.doi.org/10.1186/s12918-016-0258-3
_version_ 1782414363532984320
author Jankowski, Aleksander
Obara, Paulina
Mathur, Utsav
Tiuryn, Jerzy
author_facet Jankowski, Aleksander
Obara, Paulina
Mathur, Utsav
Tiuryn, Jerzy
author_sort Jankowski, Aleksander
collection PubMed
description BACKGROUND: The enhanceosome is an enhancer located upstream of the human interferon β gene, bound by transcription factor (TF) complex of extremely rigid structure. Within these rigid constraints, even a slight change of distances between transcription factor binding sites (TFBS) results in loss of functionality of the enhanceosome. We hypothesized that smaller subunits of the enhanceosome may entail TF complex formation in other regulatory regions. RESULTS: In order to verify this hypothesis we systematically searched for dimerization preferences of the TFs that have TFBS in the enhanceosome. For this we utilized our recently developed tool, TACO. We performed this computational experiment in a cell-type–specific manner by utilizing cell-type–specific DNase-seq data for 105 human cell types. We also used 20 TRANSFAC motifs comprising not only the usual TFs constituting the enhanceosome but also the architectural proteins of High Mobility Group I(Y) (HMG I). A similar experiment used 42 DNase-seq data sets for mouse cell types. We found 137 statistically significant dimer predictions in the human genome, and 37 predictions in the mouse genome, that matched the positioning on the enhanceosome with ±2 bp tolerance. To characterize these predicted TF dimers, we performed functional analysis (Gene Ontology enrichment) for sets of genes which were in the neighbourhood of predicted dimer instances. A notable feature of these instances is that (1) most of them are located in introns of genes, (2) they are enriched in regulatory states, and (3) those instances that are located near transcription start sites are enriched for inclusion in computationally predicted enhancers. We also investigated similarity of dimer predictions between human and mouse. CONCLUSIONS: It follows from our experiments that, except for homodimer formed by IRF proteins, the rest of the dimers were formed exclusively between one of the transcriptional activators (ATF-2/c-Jun and IRF) and a HMG I protein. NF- κB did not participate in forming dimers with other proteins. Dimers predicted in mouse were fully contained in those predicted in human, with exactly the same spacing and orientation. Intriguingly, in most of the cases the enhanceosome motifs have 1 bp wider spacing than the corresponding dimers predicted genome-wide, which is likely caused by the overall 3D structure constraints of the enhanceosome-bound complex. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-016-0258-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4743414
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47434142016-02-06 Enhanceosome transcription factors preferentially dimerize with high mobility group proteins Jankowski, Aleksander Obara, Paulina Mathur, Utsav Tiuryn, Jerzy BMC Syst Biol Research Article BACKGROUND: The enhanceosome is an enhancer located upstream of the human interferon β gene, bound by transcription factor (TF) complex of extremely rigid structure. Within these rigid constraints, even a slight change of distances between transcription factor binding sites (TFBS) results in loss of functionality of the enhanceosome. We hypothesized that smaller subunits of the enhanceosome may entail TF complex formation in other regulatory regions. RESULTS: In order to verify this hypothesis we systematically searched for dimerization preferences of the TFs that have TFBS in the enhanceosome. For this we utilized our recently developed tool, TACO. We performed this computational experiment in a cell-type–specific manner by utilizing cell-type–specific DNase-seq data for 105 human cell types. We also used 20 TRANSFAC motifs comprising not only the usual TFs constituting the enhanceosome but also the architectural proteins of High Mobility Group I(Y) (HMG I). A similar experiment used 42 DNase-seq data sets for mouse cell types. We found 137 statistically significant dimer predictions in the human genome, and 37 predictions in the mouse genome, that matched the positioning on the enhanceosome with ±2 bp tolerance. To characterize these predicted TF dimers, we performed functional analysis (Gene Ontology enrichment) for sets of genes which were in the neighbourhood of predicted dimer instances. A notable feature of these instances is that (1) most of them are located in introns of genes, (2) they are enriched in regulatory states, and (3) those instances that are located near transcription start sites are enriched for inclusion in computationally predicted enhancers. We also investigated similarity of dimer predictions between human and mouse. CONCLUSIONS: It follows from our experiments that, except for homodimer formed by IRF proteins, the rest of the dimers were formed exclusively between one of the transcriptional activators (ATF-2/c-Jun and IRF) and a HMG I protein. NF- κB did not participate in forming dimers with other proteins. Dimers predicted in mouse were fully contained in those predicted in human, with exactly the same spacing and orientation. Intriguingly, in most of the cases the enhanceosome motifs have 1 bp wider spacing than the corresponding dimers predicted genome-wide, which is likely caused by the overall 3D structure constraints of the enhanceosome-bound complex. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-016-0258-3) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-04 /pmc/articles/PMC4743414/ /pubmed/26847699 http://dx.doi.org/10.1186/s12918-016-0258-3 Text en © Jankowski et al. 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jankowski, Aleksander
Obara, Paulina
Mathur, Utsav
Tiuryn, Jerzy
Enhanceosome transcription factors preferentially dimerize with high mobility group proteins
title Enhanceosome transcription factors preferentially dimerize with high mobility group proteins
title_full Enhanceosome transcription factors preferentially dimerize with high mobility group proteins
title_fullStr Enhanceosome transcription factors preferentially dimerize with high mobility group proteins
title_full_unstemmed Enhanceosome transcription factors preferentially dimerize with high mobility group proteins
title_short Enhanceosome transcription factors preferentially dimerize with high mobility group proteins
title_sort enhanceosome transcription factors preferentially dimerize with high mobility group proteins
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743414/
https://www.ncbi.nlm.nih.gov/pubmed/26847699
http://dx.doi.org/10.1186/s12918-016-0258-3
work_keys_str_mv AT jankowskialeksander enhanceosometranscriptionfactorspreferentiallydimerizewithhighmobilitygroupproteins
AT obarapaulina enhanceosometranscriptionfactorspreferentiallydimerizewithhighmobilitygroupproteins
AT mathurutsav enhanceosometranscriptionfactorspreferentiallydimerizewithhighmobilitygroupproteins
AT tiurynjerzy enhanceosometranscriptionfactorspreferentiallydimerizewithhighmobilitygroupproteins